GW&K Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Buy |
428
+57
| +15% | +$4.4K | ﹤0.01% | 583 |
|
|
2025
Q1 | $27K | Sell |
371
-39
| -10% | -$2.84K | ﹤0.01% | 588 |
|
|
2024
Q4 | $30K | Buy |
410
+185
| +82% | +$13.5K | ﹤0.01% | 546 |
|
|
2024
Q3 | $15K | Sell |
225
-79
| -26% | -$5.27K | ﹤0.01% | 662 |
|
|
2024
Q2 | $28K | Buy |
304
+51
| +20% | +$4.7K | ﹤0.01% | 508 |
|
|
2024
Q1 | $24K | Buy |
253
+71
| +39% | +$6.74K | ﹤0.01% | 512 |
|
|
2023
Q4 | $14K | Sell |
182
-41
| -18% | -$3.15K | ﹤0.01% | 584 |
|
|
2023
Q3 | $15K | Buy |
223
+28
| +14% | +$1.88K | ﹤0.01% | 525 |
|
|
2023
Q2 | $18K | Buy |
+195
| New | +$18K | ﹤0.01% | 489 |
|
|
2022
Q3 | – | Sell |
-1,099
| Closed | -$105K | – | 547 |
|
|
2022
Q2 | $105K | Buy |
1,099
+20
| +2% | +$1.91K | ﹤0.01% | 355 |
|
|
2022
Q1 | $127K | Buy |
+1,079
| New | +$127K | ﹤0.01% | 341 |
|